Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells

Figure 1

Tamoxifen-resistant cells (TAM-R) are resistant to tamoxifen (4-OH-TAM), phenotypically distinct, more invasive and migratory compared to wild-type MCF7. (A) MCF7 and TAM-R cells treated with vehicle (EtOH) or 10-7Ā M 4-OH-TAM were plated (3 Ɨ 103/well) in 96-well plates and allowed to adhere. One plate was fixed and annotated as Day 0. A sulforhodamine B (SRB) assay was performed every two days until Day 6. The experiment was repeated three times and each time six technical replicates were used. (B) Cells were stained with Crystal Violet and 10X images were taken with a bright-field microscope when cells were 50% confluent (bar represents 400Ā Ī¼m). (C) Boyden chamber-based assay was used to determine the cells invasive or migratory capacity. Cells were allowed to invade or migrate for 72 or 18Ā hrs respectively before the insert was fixed, cut, and mounted in Mowiol infused with DAPI. 4X images were taken with a fluorescent microscope (bar represents 1,000Ā Ī¼m). The results are representative of three biological and two technical replicates. (D) Quantification of microRNA (mRNA) levels of epithelial to mesenchymal transition (EMT) markers or Notch genes (G) analysed by qRT-PCR. Fold change is shown in TAM-R compared to MCF7 cells, normalised to GAPDH. Results represent three biological as well as three technical replicates of each. (Bars represent standard deviation (SD) *P <0.05 **P <0.01, ***P <0.0001, t Student, two-tails). (E) Western blot validation for representative EMT markers and Notch proteins (H). ActinB was used as loading control. (F) Representative images showing E-cadherin expression in MCF7 and TAM-R cells at cell-cell contact.

Back to article page